Pharmacological Management of Chemotherapy-Induced Nausea and Vomiting in Children with Cancer

被引:11
作者
Cefalo, M. G. [1 ]
Ruggiero, A. [1 ]
Maurizi, P. [1 ]
Attina, G. [1 ]
Arlotta, A. [1 ]
Riccardi, R. [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Div Pediat Oncol, I-00168 Rome, Italy
关键词
Nausea; vomiting; chemotherapy; children; antiemetic agents; MODERATELY EMETOGENIC CHEMOTHERAPY; CISPLATIN-INDUCED EMESIS; ANTIEMETIC THERAPY; DOUBLE-BLIND; NEUROKININ-1; ANTAGONIST; PEDIATRIC ONCOLOGY; PHASE-III; APREPITANT; PREVENTION; ONDANSETRON;
D O I
10.1179/joc.2009.21.6.605
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nausea and vomiting are respectively the first and third most relevant chemotherapy-associated side effects in pediatric oncology, despite the introduction of new antiemetic agents. Symptoms change according to the antineoplastic agents used, and are influenced by age since emotional and psychological aspects play an important role. Studies conducted on new antiemetic therapies usually focus on adult populations affected by tumors, whereas there are very few series including pediatric patients, who are even more severely affected by this specific side effect.
引用
收藏
页码:605 / 610
页数:6
相关论文
共 50 条
  • [21] Chemotherapy-Induced Nausea and Vomiting: Incidence and Management in Jordan
    Al Qadire, Mohammad
    CLINICAL NURSING RESEARCH, 2018, 27 (06) : 730 - 742
  • [22] Treatment of Chemotherapy-Induced Nausea and Vomiting in Hematological Patients
    Avila Rueda, Jhon Alexander
    Flegler, Nicolas
    Oliveros, Karla
    Rivarola, Sofia
    Montes Ongania, Agustin
    de Muria, Mariano
    Sernaque, Cecilia
    Milena Cantillo, Ana
    Carreras, Matias
    Zapata, Luis
    Palmer, Silvina
    UNIVERSITAS MEDICA, 2021, 62 (03):
  • [23] Palonosetron hydrochloride for the prevention of chemotherapy-induced nausea and vomiting
    Ruhlmann, Christina
    Herrstedt, Jorn
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (02) : 137 - 148
  • [24] Management of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients
    Navari, Rudolph M.
    PEDIATRIC DRUGS, 2017, 19 (03) : 213 - 222
  • [25] Therapeutic effects of palonosetron plus tropisetron on chemotherapy-induced nausea and vomiting
    Liu, Liyan
    Guo, Jun
    Fang, Shu
    Han, Xiao
    Xie, Chao
    Liu, Jie
    Zhang, Xia
    Wang, Zhehai
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (04): : 4108 - 4113
  • [26] Rolapitant for the treatment of chemotherapy-induced nausea and vomiting: a review of the clinical evidence
    Chasen, Martin R.
    Rapoport, Bernardo L.
    FUTURE ONCOLOGY, 2016, 12 (06) : 763 - 778
  • [27] Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer
    Meattini, Icro
    Francolini, Giulio
    Scotti, Vieri
    Cardillo, Carla De Luca
    Cappelli, Sabrina
    Meacci, Fiammetta
    Furfaro, Ilaria Francesca
    Muntoni, Cristina
    Scoccianti, Silvia
    Detti, Beatrice
    Mangoni, Monica
    Nori, Jacopo
    Orzalesi, Lorenzo
    Fambrini, Massimiliano
    Bianchi, Simonetta
    Livi, Lorenzo
    MEDICAL ONCOLOGY, 2015, 32 (03)
  • [28] Impact of adherence to antiemetic guidelines on the incidence of chemotherapy-induced nausea and vomiting and quality of life
    Abunahlah, Nibal
    Sancar, Mesut
    Dane, Faysal
    Ozyavuz, Mustafa Kerem
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (06) : 1464 - 1476
  • [29] Rolapitant: a pooled analysis of its efficacy and safety in the prophylaxis of chemotherapy-induced nausea and vomiting
    Abdel-Rahman, Omar
    Fouad, Mona
    FUTURE ONCOLOGY, 2016, 12 (06) : 871 - 879
  • [30] Palonosetron for the treatment of chemotherapy-induced nausea and vomiting
    Navari, Rudolph M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (17) : 2599 - 2608